HK1012186A1 - Triazolones as apoliprotein-b synthesis inhibitors - Google Patents
Triazolones as apoliprotein-b synthesis inhibitorsInfo
- Publication number
- HK1012186A1 HK1012186A1 HK98113362A HK98113362A HK1012186A1 HK 1012186 A1 HK1012186 A1 HK 1012186A1 HK 98113362 A HK98113362 A HK 98113362A HK 98113362 A HK98113362 A HK 98113362A HK 1012186 A1 HK1012186 A1 HK 1012186A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- 6alkyl
- formula
- substituted
- 6alkyloxy
- halo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Saccharide Compounds (AREA)
- Seasonings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP95201010 | 1995-04-20 | ||
| PCT/EP1996/001585 WO1996033193A1 (en) | 1995-04-20 | 1996-04-12 | Novel triazolones as apolipoprotein-b synthesis inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1012186A1 true HK1012186A1 (en) | 1999-07-30 |
Family
ID=8220206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK98113362A HK1012186A1 (en) | 1995-04-20 | 1998-12-15 | Triazolones as apoliprotein-b synthesis inhibitors |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US5922718A (pt) |
| EP (1) | EP0871626B1 (pt) |
| JP (1) | JP3782455B2 (pt) |
| KR (1) | KR100413219B1 (pt) |
| CN (1) | CN1076727C (pt) |
| AT (1) | ATE208386T1 (pt) |
| AU (1) | AU699313B2 (pt) |
| CA (1) | CA2217632A1 (pt) |
| CZ (1) | CZ291737B6 (pt) |
| DE (1) | DE69616825T2 (pt) |
| DK (1) | DK0871626T3 (pt) |
| ES (1) | ES2167555T3 (pt) |
| HK (1) | HK1012186A1 (pt) |
| HU (1) | HUP9801056A3 (pt) |
| IL (1) | IL117980A (pt) |
| NO (1) | NO312415B1 (pt) |
| NZ (1) | NZ305869A (pt) |
| PL (1) | PL183737B1 (pt) |
| PT (1) | PT871626E (pt) |
| TW (1) | TW457240B (pt) |
| WO (1) | WO1996033193A1 (pt) |
| ZA (1) | ZA963152B (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2477923C (en) | 2002-03-01 | 2021-02-23 | University Of South Florida | Multiple-component solid phases containing at least one active pharmaceutical ingredient |
| MXPA05000232A (es) | 2002-06-21 | 2005-06-17 | Transform Pharmaceuticals Inc | Composiciones farmaceuticas con disolucion mejorada. |
| CA2525517C (en) * | 2003-06-19 | 2016-05-31 | Applied Research Systems Ars Holding N.V. | Use of prion conversion modulating agents |
| EP1725870A1 (en) * | 2004-03-18 | 2006-11-29 | Applied Research Systems ARS Holding N.V. | Anti-lipid rafts antibodies |
| US20070293674A1 (en) * | 2004-04-22 | 2007-12-20 | Transform Pharmaceuticals, Inc. | Novel Saperconazole Crystalline Forms and Related Processes, Pharmaceutical Compositions and Methods |
| JP2008542255A (ja) * | 2005-05-27 | 2008-11-27 | ファイザー・プロダクツ・インク | 肥満症の治療または体重減量の維持のためのカンナビノイド−１受容体アンタゴニストおよびミクロソームトリグリセリド輸送タンパク質阻害物質の併用 |
| US9663499B2 (en) | 2013-06-07 | 2017-05-30 | The California Institute For Biomedical Research | Small molecule inhibitors of fibrosis |
| KR102569494B1 (ko) | 2014-07-15 | 2023-08-21 | 이슘 리서치 디벨롭먼트 컴퍼니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. | Cd44의 단리된 폴리펩타이드 및 이의 사용 |
| AU2015360583B2 (en) | 2014-12-10 | 2020-01-23 | The Scripps Research Institute | Small molecule inhibitors of fibrosis |
| JP7071965B2 (ja) | 2017-04-11 | 2022-05-19 | 三井化学アグロ株式会社 | ピリドン化合物およびそれを有効成分とする農園芸用殺菌剤 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4101664A (en) * | 1975-10-06 | 1978-07-18 | Janssen Pharmaceutica N.V. | 1-(2-Ar-4-aryloxymethyl-1,3-dioxolan-2-ylmethyl)-imidazoles |
| US3936470A (en) * | 1975-01-27 | 1976-02-03 | Janssen Pharmaceutica N.V. | 1,3-Dioxolan-2-ylmethylimidazoles |
| US4267179A (en) * | 1978-06-23 | 1981-05-12 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles |
| US4321272A (en) * | 1980-08-25 | 1982-03-23 | Syntex (U.S.A.) Inc. | Derivatives of substituted N-alkylimidazoles |
| DE3144318A1 (de) * | 1981-11-07 | 1983-05-19 | Bayer Ag, 5090 Leverkusen | 2-imidazolylmethyl-2-phenyl-1, 3-dioxolane, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide |
| US4619931A (en) * | 1983-02-28 | 1986-10-28 | Janssen Pharmaceutica, N.V. | [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles |
| CA1292472C (en) * | 1985-12-03 | 1991-11-26 | Alfonsus Guilielmus Knaeps | Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles |
| US4791111A (en) * | 1985-12-23 | 1988-12-13 | Janssen Pharmaceutica, N.V. | [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties |
| NZ223799A (en) * | 1987-03-25 | 1989-12-21 | Janssen Pharmaceutica Nv | Azolylmethyl-dioxolanylmethoxyphenyl-piperazinyl-phenyl-triazolones and antimicrobial compositions |
| US4916134A (en) * | 1987-03-25 | 1990-04-10 | Janssen Pharmacuetica N.V. | 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones |
| AU688455B2 (en) * | 1994-01-24 | 1998-03-12 | Janssen Pharmaceutica N.V. | Watersoluble azole antifungals |
-
1996
- 1996-03-22 TW TW085103449A patent/TW457240B/zh not_active IP Right Cessation
- 1996-04-12 PT PT96910968T patent/PT871626E/pt unknown
- 1996-04-12 KR KR1019970706751A patent/KR100413219B1/ko not_active IP Right Cessation
- 1996-04-12 US US08/930,847 patent/US5922718A/en not_active Expired - Fee Related
- 1996-04-12 DE DE69616825T patent/DE69616825T2/de not_active Expired - Fee Related
- 1996-04-12 EP EP96910968A patent/EP0871626B1/en not_active Expired - Lifetime
- 1996-04-12 PL PL96322872A patent/PL183737B1/pl not_active IP Right Cessation
- 1996-04-12 AU AU53998/96A patent/AU699313B2/en not_active Ceased
- 1996-04-12 AT AT96910968T patent/ATE208386T1/de not_active IP Right Cessation
- 1996-04-12 JP JP53146096A patent/JP3782455B2/ja not_active Expired - Fee Related
- 1996-04-12 CZ CZ19973288A patent/CZ291737B6/cs not_active IP Right Cessation
- 1996-04-12 WO PCT/EP1996/001585 patent/WO1996033193A1/en active IP Right Grant
- 1996-04-12 CA CA002217632A patent/CA2217632A1/en not_active Abandoned
- 1996-04-12 NZ NZ305869A patent/NZ305869A/en unknown
- 1996-04-12 HU HU9801056A patent/HUP9801056A3/hu unknown
- 1996-04-12 ES ES96910968T patent/ES2167555T3/es not_active Expired - Lifetime
- 1996-04-12 DK DK96910968T patent/DK0871626T3/da active
- 1996-04-12 CN CN96193235A patent/CN1076727C/zh not_active Expired - Fee Related
- 1996-04-19 IL IL11798096A patent/IL117980A/xx not_active IP Right Cessation
- 1996-04-19 ZA ZA9603152A patent/ZA963152B/xx unknown
-
1997
- 1997-10-10 NO NO19974690A patent/NO312415B1/no unknown
-
1998
- 1998-12-15 HK HK98113362A patent/HK1012186A1/xx not_active IP Right Cessation
-
1999
- 1999-02-17 US US09/251,989 patent/US6197972B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DK0871626T3 (da) | 2002-02-25 |
| NO974690L (no) | 1997-10-10 |
| NZ305869A (en) | 1998-08-26 |
| ATE208386T1 (de) | 2001-11-15 |
| HUP9801056A3 (en) | 1999-09-28 |
| CZ291737B6 (cs) | 2003-05-14 |
| US6197972B1 (en) | 2001-03-06 |
| IL117980A0 (en) | 1996-08-04 |
| PT871626E (pt) | 2002-04-29 |
| NO974690D0 (no) | 1997-10-10 |
| WO1996033193A1 (en) | 1996-10-24 |
| US5922718A (en) | 1999-07-13 |
| EP0871626A1 (en) | 1998-10-21 |
| KR19980703346A (ko) | 1998-10-15 |
| ZA963152B (en) | 1997-10-20 |
| CN1181079A (zh) | 1998-05-06 |
| JPH11503739A (ja) | 1999-03-30 |
| AU699313B2 (en) | 1998-12-03 |
| ES2167555T3 (es) | 2002-05-16 |
| KR100413219B1 (ko) | 2004-05-31 |
| DE69616825D1 (en) | 2001-12-13 |
| CN1076727C (zh) | 2001-12-26 |
| JP3782455B2 (ja) | 2006-06-07 |
| DE69616825T2 (de) | 2002-06-27 |
| PL183737B1 (pl) | 2002-07-31 |
| TW457240B (en) | 2001-10-01 |
| CA2217632A1 (en) | 1996-10-24 |
| NO312415B1 (no) | 2002-05-06 |
| PL322872A1 (en) | 1998-03-02 |
| EP0871626B1 (en) | 2001-11-07 |
| CZ328897A3 (cs) | 1998-01-14 |
| IL117980A (en) | 2000-02-17 |
| AU5399896A (en) | 1996-11-07 |
| HUP9801056A2 (hu) | 1999-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0201646A2 (hu) | Új alfa-aminosav vegyületek, eljárás ezek előállítására, és ezeket tartalmazó gyógyászati készítmények | |
| MY102866A (en) | Amide derivatives. | |
| AP1541A (en) | New thiadazoles and oxadiazoles and their use as phosphodiesterase - 7 inhibitors. | |
| DK0794949T3 (da) | Hidtil ukendte 3,5-dioxo-(2H,4H)-1,2,4-triazinderivater, fremstilling heraf og deres anvendelse som lægemidler | |
| AU7517400A (en) | N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent | |
| HK1012186A1 (en) | Triazolones as apoliprotein-b synthesis inhibitors | |
| MY132062A (en) | Apolipoprotein-b synthesis inhibitors | |
| BG104717A (en) | Water soluble azoles as broad-spectrum antifungals | |
| HUP0104308A2 (hu) | Amidino- és guanidino-azetidinon-származékok, mint triptáz inhibitorok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények, valamint intermedierek | |
| DE69323322D1 (de) | Verwendung dimethylbenzofuran und dimethylbenzopyran derivate als 5-ht3 antagoniste | |
| HUP0402515A2 (hu) | Szubsztituált új N-[4-(1H-imidazol-1-il)-2-fluor-fenil]-3-(trifluor-metil)-1H-pirazol-5-karboxamidok Xa faktor inhibitorok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
| NO971376D0 (no) | N-substituerte piperidinyl bisykliske benzoatderivater | |
| MY140653A (en) | Substituted diketopiperazines and their use as oxytocyn antagonists | |
| SE9904177D0 (sv) | Novel compounds | |
| AP1396A (en) | 1-Trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives. | |
| MY113584A (en) | Prokinetic oxadiazoles | |
| DE69617001D1 (de) | (2-morpholinylmethyl)benzamid-derivate | |
| FI962120A (fi) | Estramustiiniformulaatiot, joilla on parannetut farmaseuttiset ominaisuudet | |
| MX9704667A (es) | 6-[triazolil[3-trifluorometil)fenil]metil]-2-quinolinonas y quinolinotionas. | |
| MX9703074A (es) | Inhibidores de sintesis de apoliproteina-b. | |
| YU79401A (sh) | Derivati 1-trifluorometil-4-hidroksi-7-piperidinil- aminometilhromana | |
| JO1648B1 (en) | Nitrogen compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PF | Patent in force | ||
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20060412 |